1. Home
  2. WULF vs NVAX Comparison

WULF vs NVAX Comparison

Compare WULF & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

HOLD

Current Price

$11.39

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.74

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WULF
NVAX
Founded
1952
1987
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
1.1B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
WULF
NVAX
Price
$11.39
$6.74
Analyst Decision
Strong Buy
Hold
Analyst Count
12
8
Target Price
$17.04
$9.75
AVG Volume (30 Days)
28.1M
3.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$167,604,000.00
$1,064,651,000.00
Revenue This Year
$30.84
$58.91
Revenue Next Year
$123.19
N/A
P/E Ratio
N/A
$3.29
Revenue Growth
30.58
20.27
52 Week Low
$2.06
$5.01
52 Week High
$17.05
$11.55

Technical Indicators

Market Signals
Indicator
WULF
NVAX
Relative Strength Index (RSI) 38.69 45.92
Support Level $11.32 $6.36
Resistance Level $13.64 $7.00
Average True Range (ATR) 1.08 0.20
MACD -0.27 0.06
Stochastic Oscillator 2.71 60.16

Price Performance

Historical Comparison
WULF
NVAX

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: